摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethyl I+/--ethyl-4-hydroxybenzenepropanoate | 1075742-27-6

中文名称
——
中文别名
——
英文名称
Ethyl I+/--ethyl-4-hydroxybenzenepropanoate
英文别名
ethyl 2-[(4-hydroxyphenyl)methyl]butanoate
Ethyl I+/--ethyl-4-hydroxybenzenepropanoate化学式
CAS
1075742-27-6
化学式
C13H18O3
mdl
——
分子量
222.284
InChiKey
TXFYCQCPBISFEI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    16
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    碳酸乙烯酯Ethyl I+/--ethyl-4-hydroxybenzenepropanoatepotassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 Ethyl 2-[[4-(2-hydroxyethoxy)phenyl]methyl]butanoate
    参考文献:
    名称:
    Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARα/γ dual agonists
    摘要:
    Aryl-tetrahydropyridine derivatives were prepared and their PPAR alpha/gamma dual agonistic activities were evaluated. Among them, compound (S)-5b was identified as a potent PPAR alpha/gamma dual agonist with an EC50 of 1.73 and 0.64 mu M in hPPAR alpha and gamma, respectively. In diabetic (db/db) mice, compound (S)-5b showed good glucose lowering efficacy and favorable pharmacokinetic properties. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.08.020
点击查看最新优质反应信息

文献信息

  • Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARα/γ dual agonists
    作者:Eunkyung Kim、Chan Sun Park、Taedong Han、Myung-Ho Bae、Wonee Chong、Choong Hyun Lee、Young Ah Shin、Byung-Nak Ahn、Mi Kyung Kim、Chang Yell Shin、Moon Ho Son、Jin Kwan Kim、Ho Sang Moon、Hyun Joo Shim、Eun Jung Kim、Soon Hoe Kim、Joong In Lim、Chun Ho Lee
    DOI:10.1016/j.bmcl.2008.08.020
    日期:2008.9
    Aryl-tetrahydropyridine derivatives were prepared and their PPAR alpha/gamma dual agonistic activities were evaluated. Among them, compound (S)-5b was identified as a potent PPAR alpha/gamma dual agonist with an EC50 of 1.73 and 0.64 mu M in hPPAR alpha and gamma, respectively. In diabetic (db/db) mice, compound (S)-5b showed good glucose lowering efficacy and favorable pharmacokinetic properties. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多